Clinical characteristics of the study subjects.
| Characteristics | SLE, n = 151(%) | Controls, n = 151(%) | SLE vs Controls, p |
|---|---|---|---|
| Age, yrs, mean ± SD | 34.21 ± 12.35 | 26.16 ± 4.27 | 0.001 |
| Men | 28 (18.5) | 34 (22.5) | 0.393 |
| Women | 123 (81.5) | 117 (77.5) | |
| Oral ulcer | 72 (47.7) | ||
| Arthritis | 102 (67.5) | ||
| Serositis | 24 (15.9) | ||
| Rash | 68 (45.0) | ||
| Nephritis | 51 (33.8) | ||
| Leukopenia | 92 (60.9) | ||
| Lymphopenia | 139 (92.1) | ||
| Thrombocytopenia | 37 (24.5) | ||
| Anti-dsDNA | 108 (71.5) | ||
| Hypocomplementemia | 114 (75.5) | ||
| Anticardiolipin antibody | 63 (41.7) | ||
| Major organ involvement | 69 (45.7) | ||
| C-reactive protein (mg/dl, mean ± SD) | 0.063 ± 0.121 |
SLE: systemic lupus erythematosus.